However, the traits that contribute to the transition of E. faecium from a commensal to a nosocomial pathogen have not been identified [16]. Molecular
typing methods are essential click here for identifying hospital-associated outbreaks of E. faecium. Multilocus sequence typing (MLST) has revealed the existence of host-specific genogroups, including a specific genetic lineage designated VS-4718 mouse clonal complex 17, associated with hospital-related isolates [1, 17]. MLST of E. faecium is based on identifying alleles from DNA sequences in internal fragments of housekeeping genes (atpA, ddl, gdh, purK, gyd, pstS and adk), resulting in a numeric allelic profile, with each profile then being assigned a sequence type (ST) [17]. Complex 17 most likely evolved Selleckchem CA4P from the primary E. faecium ancestor ST-22, while ST-17 represents an important secondary founder with additional linages designated to complex 17 [18]. Clonal
complex 17 is characterized by ampicillin and quinolone resistance and the presence of a putative pathogenicity island that includes the esp and/or hyl genes in the majority of isolates [1, 18–20]. Various STs belonging to clonal complex 17, such as ST16, ST17, ST18, ST203 and ST412, are currently being disseminated worldwide [21, 22]. Interestingly, half of the STs within the clonal complex 17 polyclonal subpopulation have also been identified in samples obtained from healthy humans, swine, poultry and pets [16]. In Mexico, there is little available information about the prevalence of VREF CYTH4 isolates, and no study related to clonal complex 17 has been performed in pediatric patients. The aim of this study was to genotypically and phenotypically characterize VREF clinical isolates from 12 immunocompromised pediatric patients at the Hospital Infantil de México Federico
Gómez (HIMFG). This study involved amplification of the resistance genes vanA and vanB and two virulence genes (esp and hyl) and molecular typing via pulsed-field gel electrophoresis (PFGE) and MLST. Methods Bacterial isolates Twelve E. faecium isolates of clinical importance were obtained from 12 patients with nosocomial infections in the PICU (Pediatric Intensive Care Unit), oncology, gastroenterology and transplant wards of HIMFG during the period from July 2009 to April 2011. The isolates were maintained at −70°C in skim milk (Becton Dickinson, New Jersey, USA) and cultured on 5% sheep blood agar plates (Becton Dickinson, New Jersey, USA) at 37°C under 5% CO2 for 24 h. The E. faecalis ATCC® 29212, E. faecalis ATCC® 51299 and E. faecium ATCC® 51559 strains (American Type Culture Collection Manassas, VA, USA) were used as controls. Biochemical tests Bacteria were grown on blood agar, and identification was performed using manual methods.